Skip to content

CTT PHARMACEUTICAL HOLDINGS, INC.

CTTH

CIK 0001035422

← back to feed
Revenue (TTM)
—
Q3 Nov 2015
Net Income (TTM)
−$1.08M
−3,454.3% YoY Q3 Nov 2015
EPS Diluted (TTM)
−$0.01
+109.1% YoY Q3 Nov 2015
Gross Margin
—
Q3 Nov 2015
Operating Margin
—
Q3 Nov 2015
Net Margin
—
Q3 Nov 2015
Free Cash Flow (TTM)
—
Q3 Nov 2015
Cash
$32.12K
Q3 Nov 2015
Total Debt
—
Q3 Nov 2015
Shares Outstanding
21.35M sh
Q3 Nov 2015

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings